Article Information
History
- October 4, 2022.
Article Versions
- Version 1 (May 31, 2022 - 20:45).
- Version 2 (July 19, 2022 - 14:07).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Regina H. Reynolds1,2,#,*,
- Aaron Z. Wagen1,3,4,#,
- Frida Lona-Durazo5,
- Sonja W. Scholz6,7,
- Maryam Shoai8,10,
- John Hardy2,8,10,
- Sarah A. Gagliano Taliun5,9 and
- Mina Ryten1,2,11,*
- 1Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK
- 2Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, United States
- 3Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, London, UK
- 4Neurodegeneration Biology Laboratory, The Francis Crick Institute, London, UK
- 5Montréal Heart Institute, Montréal, Québec, Canada
- 6Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
- 7Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA
- 8Department of Neurodegenerative Diseases, Queen Square Institute of Neurology, University College London, London, UK
- 9Department of Medicine & Department of Neurosciences, Université de Montréal, Montréal, Québec, Canada
- 10UK Dementia Research Institute, University College London, London, UK
- 11NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK
- ↵*Correspondence to:
Regina H. Reynolds (regina.reynolds.16{at}ucl.ac.uk) & Mina Ryten (mina.ryten{at}ucl.ac.uk)
↵# These authors contributed equally to this work.